Circulating osteoprotegerin is increased in the metabolic syndrome and associates with subclinical atherosclerosis and coronary arterial calcification

  1. Pérez de Ciriza, C.
  2. Moreno, M.
  3. Restituto, P.
  4. Bastarrika, G.
  5. Simón, I.
  6. Colina, I.
  7. Varo, N.
Journal:
Clinical Biochemistry

ISSN: 1873-2933,  0009-9120

Year of publication: 2014

Volume: 47

Issue: 18

Pages: 272-278

Type: Article

DOI: 10.1016/J.CLINBIOCHEM.2014.09.004 GOOGLE SCHOLAR

Sustainable development goals

Data source: Scopus